世界の転移性結腸直腸癌治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Metastatic Colorectal Cancer Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4497
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、転移性結腸直腸癌治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外科、化学療法）、用途別市場規模（病院、クリニック、がん研究センター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・転移性結腸直腸癌治療の市場動向
・企業の競争状況、市場シェア
・転移性結腸直腸癌治療の種類別市場規模と予測2016-2027（外科、化学療法）
・転移性結腸直腸癌治療の用途別市場規模と予測2016-2027（病院、クリニック、がん研究センター）
・転移性結腸直腸癌治療の北米市場規模2016-2027（アメリカ、カナダ）
・転移性結腸直腸癌治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・転移性結腸直腸癌治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・転移性結腸直腸癌治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・転移性結腸直腸癌治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Sanofi、Roche、Eli Lilly、Pfizer、Novartis、Amgen、Taiho Oncology、Genentech、EMD Serono、Suzhou Zelgen Biopharmaceuticals）
・結論

Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body parts i.e. metastatic colorectal cancers are difficult to treat and have 11%-12% 5-year relative survival rate.
Treatment of metastatic colorectal cancer is multidisciplinary field involving early evaluation for resection of hepatic metastasis, metastasectomy and coordinated chemotherapy or radiation therapy. Primary factors driving growth of metastatic colorectal cancer treatment market are increasing prevalence of colorectal cancer across the globe, rapid innovation in personalized medicine and discovery of new targets for treatment of colorectal cancers.

Market Analysis and Insights: Global Metastatic Colorectal Cancer Treatment Market
The global Metastatic Colorectal Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metastatic Colorectal Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metastatic Colorectal Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metastatic Colorectal Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metastatic Colorectal Cancer Treatment market.

Global Metastatic Colorectal Cancer Treatment Scope and Market Size
Metastatic Colorectal Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metastatic Colorectal Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Surgery
Chemotherapy

Segment by Application
Hospitals
Clinics
Cancer Research Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi
Roche
Eli Lilly
Pfizer
Novartis
Amgen
Taiho Oncology
Genentech
EMD Serono
Suzhou Zelgen Biopharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Chemotherapy
1.3 Market by Application
1.3.1 Global Metastatic Colorectal Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Research Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Metastatic Colorectal Cancer Treatment Market Perspective (2016-2027)
2.2 Metastatic Colorectal Cancer Treatment Growth Trends by Regions
2.2.1 Metastatic Colorectal Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Metastatic Colorectal Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Metastatic Colorectal Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Metastatic Colorectal Cancer Treatment Industry Dynamic
2.3.1 Metastatic Colorectal Cancer Treatment Market Trends
2.3.2 Metastatic Colorectal Cancer Treatment Market Drivers
2.3.3 Metastatic Colorectal Cancer Treatment Market Challenges
2.3.4 Metastatic Colorectal Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Metastatic Colorectal Cancer Treatment Players by Revenue
3.1.1 Global Top Metastatic Colorectal Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Metastatic Colorectal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metastatic Colorectal Cancer Treatment Revenue
3.4 Global Metastatic Colorectal Cancer Treatment Market Concentration Ratio
3.4.1 Global Metastatic Colorectal Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastatic Colorectal Cancer Treatment Revenue in 2020
3.5 Metastatic Colorectal Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Metastatic Colorectal Cancer Treatment Product Solution and Service
3.7 Date of Enter into Metastatic Colorectal Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Metastatic Colorectal Cancer Treatment Breakdown Data by Type
4.1 Global Metastatic Colorectal Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Metastatic Colorectal Cancer Treatment Breakdown Data by Application
5.1 Global Metastatic Colorectal Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Metastatic Colorectal Cancer Treatment Market Size (2016-2027)
6.2 North America Metastatic Colorectal Cancer Treatment Market Size by Type
6.2.1 North America Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Metastatic Colorectal Cancer Treatment Market Size by Application
6.3.1 North America Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Metastatic Colorectal Cancer Treatment Market Size by Country
6.4.1 North America Metastatic Colorectal Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Metastatic Colorectal Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Metastatic Colorectal Cancer Treatment Market Size (2016-2027)
7.2 Europe Metastatic Colorectal Cancer Treatment Market Size by Type
7.2.1 Europe Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Metastatic Colorectal Cancer Treatment Market Size by Application
7.3.1 Europe Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Metastatic Colorectal Cancer Treatment Market Size by Country
7.4.1 Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Metastatic Colorectal Cancer Treatment Market Size (2016-2027)
9.2 Latin America Metastatic Colorectal Cancer Treatment Market Size by Type
9.2.1 Latin America Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Metastatic Colorectal Cancer Treatment Market Size by Application
9.3.1 Latin America Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Metastatic Colorectal Cancer Treatment Market Size by Country
9.4.1 Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Metastatic Colorectal Cancer Treatment Introduction
11.1.4 Sanofi Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Metastatic Colorectal Cancer Treatment Introduction
11.2.4 Roche Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Metastatic Colorectal Cancer Treatment Introduction
11.3.4 Eli Lilly Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Metastatic Colorectal Cancer Treatment Introduction
11.4.4 Pfizer Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Metastatic Colorectal Cancer Treatment Introduction
11.5.4 Novartis Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Metastatic Colorectal Cancer Treatment Introduction
11.6.4 Amgen Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.6.5 Amgen Recent Development
11.7 Taiho Oncology
11.7.1 Taiho Oncology Company Details
11.7.2 Taiho Oncology Business Overview
11.7.3 Taiho Oncology Metastatic Colorectal Cancer Treatment Introduction
11.7.4 Taiho Oncology Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.7.5 Taiho Oncology Recent Development
11.8 Genentech
11.8.1 Genentech Company Details
11.8.2 Genentech Business Overview
11.8.3 Genentech Metastatic Colorectal Cancer Treatment Introduction
11.8.4 Genentech Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.8.5 Genentech Recent Development
11.9 EMD Serono
11.9.1 EMD Serono Company Details
11.9.2 EMD Serono Business Overview
11.9.3 EMD Serono Metastatic Colorectal Cancer Treatment Introduction
11.9.4 EMD Serono Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.9.5 EMD Serono Recent Development
11.10 Suzhou Zelgen Biopharmaceuticals
11.10.1 Suzhou Zelgen Biopharmaceuticals Company Details
11.10.2 Suzhou Zelgen Biopharmaceuticals Business Overview
11.10.3 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Treatment Introduction
11.10.4 Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.10.5 Suzhou Zelgen Biopharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Chemotherapy
Table 4. Global Metastatic Colorectal Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Metastatic Colorectal Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Metastatic Colorectal Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Metastatic Colorectal Cancer Treatment Market Share by Regions (2016-2021)
Table 8. Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Metastatic Colorectal Cancer Treatment Market Share by Regions (2022-2027)
Table 10. Metastatic Colorectal Cancer Treatment Market Trends
Table 11. Metastatic Colorectal Cancer Treatment Market Drivers
Table 12. Metastatic Colorectal Cancer Treatment Market Challenges
Table 13. Metastatic Colorectal Cancer Treatment Market Restraints
Table 14. Global Metastatic Colorectal Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Metastatic Colorectal Cancer Treatment Market Share by Players (2016-2021)
Table 16. Global Top Metastatic Colorectal Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Colorectal Cancer Treatment as of 2020)
Table 17. Ranking of Global Top Metastatic Colorectal Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Metastatic Colorectal Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Metastatic Colorectal Cancer Treatment Product Solution and Service
Table 21. Date of Enter into Metastatic Colorectal Cancer Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Metastatic Colorectal Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Metastatic Colorectal Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Metastatic Colorectal Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Sanofi Company Details
Table 62. Sanofi Business Overview
Table 63. Sanofi Metastatic Colorectal Cancer Treatment Product
Table 64. Sanofi Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Metastatic Colorectal Cancer Treatment Product
Table 69. Roche Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Eli Lilly Company Details
Table 72. Eli Lilly Business Overview
Table 73. Eli Lilly Metastatic Colorectal Cancer Treatment Product
Table 74. Eli Lilly Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 75. Eli Lilly Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Metastatic Colorectal Cancer Treatment Product
Table 79. Pfizer Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Metastatic Colorectal Cancer Treatment Product
Table 84. Novartis Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Amgen Company Details
Table 87. Amgen Business Overview
Table 88. Amgen Metastatic Colorectal Cancer Treatment Product
Table 89. Amgen Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 90. Amgen Recent Development
Table 91. Taiho Oncology Company Details
Table 92. Taiho Oncology Business Overview
Table 93. Taiho Oncology Metastatic Colorectal Cancer Treatment Product
Table 94. Taiho Oncology Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 95. Taiho Oncology Recent Development
Table 96. Genentech Company Details
Table 97. Genentech Business Overview
Table 98. Genentech Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 99. Genentech Recent Development
Table 100. EMD Serono Company Details
Table 101. EMD Serono Business Overview
Table 102. EMD Serono Metastatic Colorectal Cancer Treatment Product
Table 103. EMD Serono Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 104. EMD Serono Recent Development
Table 105. Suzhou Zelgen Biopharmaceuticals Company Details
Table 106. Suzhou Zelgen Biopharmaceuticals Business Overview
Table 107. Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Treatment Product
Table 108. Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 109. Suzhou Zelgen Biopharmaceuticals Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Colorectal Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Chemotherapy Features
Figure 4. Global Metastatic Colorectal Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Cancer Research Centers Case Studies
Figure 8. Metastatic Colorectal Cancer Treatment Report Years Considered
Figure 9. Global Metastatic Colorectal Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Metastatic Colorectal Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Metastatic Colorectal Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Metastatic Colorectal Cancer Treatment Market Share by Regions (2022-2027)
Figure 13. Global Metastatic Colorectal Cancer Treatment Market Share by Players in 2020
Figure 14. Global Top Metastatic Colorectal Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Colorectal Cancer Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Metastatic Colorectal Cancer Treatment Revenue in 2020
Figure 16. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Metastatic Colorectal Cancer Treatment Market Share by Type (2016-2027)
Figure 20. North America Metastatic Colorectal Cancer Treatment Market Share by Application (2016-2027)
Figure 21. North America Metastatic Colorectal Cancer Treatment Market Share by Country (2016-2027)
Figure 22. United States Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Metastatic Colorectal Cancer Treatment Market Share by Type (2016-2027)
Figure 26. Europe Metastatic Colorectal Cancer Treatment Market Share by Application (2016-2027)
Figure 27. Europe Metastatic Colorectal Cancer Treatment Market Share by Country (2016-2027)
Figure 28. Germany Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Share by Region (2016-2027)
Figure 38. China Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Metastatic Colorectal Cancer Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Metastatic Colorectal Cancer Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Metastatic Colorectal Cancer Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Sanofi Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 58. Roche Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 59. Eli Lilly Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 62. Amgen Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 63. Taiho Oncology Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 64. Genentech Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 65. EMD Serono Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 66. Suzhou Zelgen Biopharmaceuticals Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の転移性膵がん治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Pancreatic Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4499 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、転移性膵がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、その他）、用途別市場規模（外分泌、内分泌）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の転移性乳がん治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Breast Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4496 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、転移性乳がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、生物学的標的療法、乳腺手術、ホルモン療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、...

世界の転移性骨がん薬物治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Bones Cancer Medication Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5856 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、転移性骨がん薬物治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、ホルモン療法、ビスフォスフォネート、アヘン剤療法、免疫療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規...

世界の結腸直腸癌治療市場規模・現状・予測（2021年-2027年）

Global Colorectal Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4037 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、結腸直腸癌治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（標的療法、免疫療法、化学療法、その他）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の転移性前立腺がん治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5858 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、転移性前立腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単体、複合、単体/複合）、用途別市場規模（病院、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の転移性骨がん市場規模・現状・予測（2021年-2027年）

Global Metastatic Bones Cancer Market Size, Status and Forecast 2021-2027
QFJ1-5855 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、転移性骨がんの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、放射線療法、外科的介入、腫瘍切除療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の遺伝性大腸がん分子診断市場規模・現状・予測（2021年-2027年）

Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Size, Status and Forecast 2021-2027
QFJ1-4518 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、遺伝性大腸がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（...

世界の結腸直腸がんスクリーニング市場規模・現状・予測（2021年-2027年）

Global Colorectal Cancer Screening Market Size, Status and Forecast 2021-2027
QFJ1-4036 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、結腸直腸がんスクリーニングの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（糞便検査、大腸内視鏡検査、CTコロノグラフィー、その他）、用途別市場規模（病院、独立診断研究所、その他）、主要地域別市場規模（...

世界の結腸直腸癌診断市場規模・現状・予測（2021年-2027年）

Global Colorectal Cancer Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-5128 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、結腸直腸癌診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（FOB検査、CTC検査、CEA検査、その他）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の転移性黒色腫治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Melanoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4498 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、転移性黒色腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（標的化学療法、標的免疫療法、標的MAPキナーゼ療法、抗血管新生療法、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他...

世界の転移性乳がん治療市場規模・現状・予測（2021年-2027年） Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
世界の転移性膵がん治療市場規模・現状・予測（2021年-2027年） Metastatic pancreatic cancer treatment, when cancer spreads outside of the pancreas, surgery may or may not be recommended. It’s more common for oncologists to recommend systemic treatments (which can circulate throughout the entire body and destroy cancerous cells in multiple locations) for metasta…
世界の転移性骨がん薬物治療市場規模・現状・予測（2021年-2027年） Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types ofcancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to bone, including breast cancer and prostatecancer Market Analysis and Insights: Global Met…
世界の結腸直腸癌治療市場規模・現状・予測（2021年-2027年） Colorectal cancer therapeutics market trends, there are a number of factors providing major impetus to the growth of these drugs. Market Analysis and Insights: Global Colorectal Cancer Treatment Market The global Colorectal Cancer Treatment market size is projected to reach US$ XX million by 2027, f…
世界の転移性前立腺がん治療市場規模・現状・予測（2021年-2027年） Metastatic prostate cancer is a type of prostate cancer which spreads to the other parts of body such as bones or lymph nodes. Market Analysis and Insights: Global Metastatic Prostate Cancer Treatment Market The global Metastatic Prostate Cancer Treatment market size is projected to reach US$ XX mil…